Stock Analiz

Cosmos Health Inc. COSM

Other Pharmaceuticals · data as of November 13, 2026

$3.24Market cap $326M
Open the interactive analysis →

Cosmos Health Inc. (COSM) is a healthcare company listed in the US with a market value of about $326M. In the twelve months to June 30, 2026 it had revenue of $74M and net income of -$24M, a net margin of -33.1%.

Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is future growth (2/5); the weakest is value (0/5).

Key numbers: 5-year revenue growth of 3% a year, a 5-year average ROIC of -42%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 97% below the current price.

About Cosmos Health

Cosmos Health is listed in the US and classified in other pharmaceuticals. Revenue went from $8M in 2014 to $65M in 2025, growth of about 21.5% a year. It was profitable in 1 of the last 10 years in our data. Its share count rose by 1471% over three years (dilution for shareholders). It spends 1% of revenue on research and development.

Score: 0.8 / 5

Value0/5
Future growth2/5
Track record0/5
Financial health1/5
Shareholder returns1/5

Checks passed

  • Revenue growth above 10% last year
  • Profit margin improving
  • More cash than debt, or low debt to equity
  • Stock-based pay below 5% of revenue

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • 3-year revenue growth above 10% a year
  • 3-year free cash flow growth above 10% a year
  • Strong R&D investment or growth above 20%

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S4.4
P/B15.8
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-3.0%
Shareholder yield0.0%
Intrinsic value vs. price−97%

Growth and quality

Revenue growth (1 yr)19.9%
Revenue growth (5 yrs, per year)3.3%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-27.1%
ROIC (5-yr avg.)-41.9%
Profitable years (of last 10)1
Years paying a dividend—

Financials, last 10 years

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$74M$65M$54M$53M$50M$56M$55M$40M$37M$30M$7M
Net income-$24M-$19M-$16M-$19M-$14M-$8M$820786-$3M-$9M-$6M-$601002
Free cash flow-$10M-$9M-$8M-$17M-$15M-$8M-$12M—-$2M-$9M-$2M
EPS (diluted)$-0.64$-0.63$-1.17$-2.15$-33.16$-23.74$1.50$-6.25$-17.00$-12.25$2018526.23
Net margin-33.1%-29.3%-29.7%-34.7%-27.5%-14.2%1.5%-8.3%-24.4%-20.7%-8.9%
ROIC—-73.3%-53.0%-52.2%-15.5%-15.5%11.0%-3.3%-18.9%——

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Is Cosmos Health stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 97% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Cosmos Health pay a dividend?

Not currently.

Is Cosmos Health a good stock to buy?

We do not give buy or sell advice. Cosmos Health scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.